Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "698eccba9206f8f071919fc7",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "clobetasol neomycin miconazole cream",
"description": "EUROSOFT 4D CREAM represents a sophisticated breakthrough in topical dermatological therapy, combining three powerful active ingredients—clobetasol propionate, neomycin sulfate, and miconazole nitrate—into one comprehensive treatment formulation. This advanced pharmaceutical preparation is specifically designed to address complex skin conditions that involve inflammation, bacterial infection, and fungal colonization simultaneously. The “4D” designation reflects the cream's multidimensional approach to skin healing: it reduces inflammation, eliminates bacterial pathogens, eradicates fungal infections, and promotes overall skin restoration.This prescription-strength cream has been formulated using advanced pharmaceutical technology to ensure optimal penetration, stability, and efficacy. Each gram of EUROSOFT 4D CREAM delivers precise therapeutic doses of its active components, working synergistically to provide rapid relief and comprehensive healing for challenging dermatological conditions that might otherwise require multiple separate medications.Comprehensive Uses and ApplicationsEUROSOFT 4D CREAM is prescribed for a diverse range of dermatological conditions where multiple pathogenic factors contribute to skin disease. The primary indications include infected eczema, where both inflammation and secondary bacterial or fungal infection complicate the condition. Patients suffering from seborrheic dermatitis with secondary infection find significant relief with this triple-action formulation, as it addresses both the inflammatory component and the microbial colonization that often perpetuates this chronic condition.The cream proves particularly valuable in treating intertrigo—inflammatory conditions occurring in skin folds—where moisture, friction, and warmth create an ideal environment for both bacterial and fungal proliferation alongside inflammatory responses. Athletes dealing with infected dermatoses, including cases where fungal infections like tinea have become complicated by bacterial superinfection, benefit from the comprehensive coverage this medication provides.Contact dermatitis cases that have developed secondary infections respond well to EUROSOFT 4D CREAM, as the corticosteroid component addresses the allergic or irritant inflammatory response while the antimicrobial agents tackle opportunistic infections. The cream is also employed in managing various forms of infected psoriasis, particularly in intertriginous areas where both inflammation and infection coexist, creating a challenging therapeutic scenario.Medical professionals may prescribe this formulation for other complex dermatological conditions where the simultaneous presence of inflammation, bacterial infection, and fungal colonization requires a multifaceted treatment approach. The convenience of a single application containing all three therapeutic agents significantly improves patient compliance compared to using multiple separate medications.Key Benefits and Therapeutic AdvantagesThe primary advantage of EUROSOFT 4D CREAM lies in its comprehensive, multi-targeted action. The clobetasol propionate component is a super-potent corticosteroid that rapidly suppresses inflammation, reducing redness, swelling, itching, and discomfort. This powerful anti-inflammatory effect provides quick symptomatic relief, often noticeable within the first few applications, dramatically improving patient comfort and quality of life.Neomycin sulfate, a broad-spectrum aminoglycoside antibiotic, effectively eliminates a wide range of gram-positive and gram-negative bacteria commonly responsible for secondary skin infections. By controlling bacterial proliferation, it prevents infection from spreading, reduces the risk of complications, and accelerates the healing process. This antibacterial protection is crucial in preventing the vicious cycle where infection perpetuates inflammation and vice versa.The miconazole nitrate component provides robust antifungal coverage against dermatophytes, yeasts, and other pathogenic fungi that frequently complicate inflammatory skin conditions. Its fungicidal action ensures complete eradication of fungal elements, preventing recurrence and breaking the cycle of persistent infection that can undermine other therapeutic efforts.The synergistic formulation means patients need only one medication rather than juggling multiple creams or ointments, significantly simplifying their treatment regimen. This convenience improves adherence to prescribed therapy, leading to better outcomes. The cream base is designed for optimal absorption and comfortable application, avoiding the greasiness or stickiness that might deter regular use.EUROSOFT 4D CREAM typically produces visible improvements within days, though complete resolution requires completing the full prescribed course. The rapid symptom relief—particularly reduction in itching, pain, and visible inflammation—provides significant psychological and physical comfort to patients struggling with distressing skin conditions. By addressing all three pathological factors simultaneously, the cream prevents the common problem of treating one aspect of the condition while another remains unaddressed and continues causing symptoms.Important Side Effects and PrecautionsWhile EUROSOFT 4D CREAM is highly effective, users should be aware of potential side effects associated with its potent active ingredients. The clobetasol component, being a super-potent corticosteroid, can cause skin thinning (atrophy), stretch marks (striae), telangiectasia (visible blood vessels), and changes in skin pigmentation with prolonged use. These effects are more likely when the cream is used on thin-skinned areas like the face, groin, or underarms, or when applied under occlusive dressings.Systemic absorption of clobetasol, particularly with extensive application or prolonged use, may suppress the hypothalamic-pituitary-adrenal (HPA) axis, potentially affecting the body's natural cortisol production. This is especially concerning in children, whose body surface area to weight ratio makes them more vulnerable to systemic effects. Other corticosteroid-related effects may include acne-like eruptions, perioral dermatitis, delayed wound healing, and increased susceptibility to skin infections if protective immunity is compromised.Neomycin can cause contact sensitization in susceptible individuals, leading to allergic contact dermatitis. This manifests as increased redness, itching, or rash that paradoxically worsens with continued use. Cross-sensitivity with other aminoglycoside antibiotics is possible. Though rare with topical application, systemic absorption of neomycin could theoretically cause ototoxicity or nephrotoxicity, particularly if applied to large surface areas or compromised skin.Miconazole is generally well-tolerated but can occasionally cause local irritation, burning, or allergic reactions. Some users report mild stinging upon initial application, which typically subsides with continued use.Users should avoid applying the cream to the face for extended periods, near the eyes, or on broken skin unless specifically directed by their healthcare provider. The medication should not be used during pregnancy or breastfeeding without medical supervision. Parents should exercise particular caution when using this cream on children, as pediatric patients are more susceptible to systemic corticosteroid effects.If symptoms worsen, if new symptoms develop, or if no improvement occurs after one week of use, patients should consult their healthcare provider promptly. Signs of possible adverse reactions include excessive irritation, severe itching, rash expansion, or signs of spreading infection.ConclusionEUROSOFT 4D CREAM represents an innovative and highly effective solution for complex dermatological conditions requiring simultaneous anti-inflammatory, antibacterial, and antifungal therapy. Its triple-action formulation addresses the multifaceted nature of infected inflammatory skin diseases, providing comprehensive treatment in a single convenient application. The synergistic combination of clobetasol propionate, neomycin sulfate, and miconazole nitrate delivers rapid symptom relief while promoting complete healing.",
"price": 91.0,
"discountamount": 27.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2302,
"imageuri": "https://productimages.withfloats.com/actual/698eccbd3d2f9770ce0bdd1c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/698eccbd3d2f9770ce0bdd1c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-02-13T07:03:22.253Z",
"updatedon": "2026-03-12T08:14:48.969Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/clobetasol-neomycin-miconazole-cream/2302",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "EUROSOFT 4D CREAM",
"category": "DERMATALOGY",
"tags": [
"Clobetasol Neomycin Miconazole cream",
"Clobetasol combination antifungal cream",
"Clobetasol Neomycin Miconazole Chlorhexidine cream",
"Triple action steroid antibiotic antifungal cream",
"Miconazole Neomycin steroid skin cream",
"Clobetasol Neomycin antifungal cream 0.5%"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ae5ddc42400c0ad258fb750",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Mycophenolic Acid Delayed-Release Tablets USP 360 mg",
"description": "MYCOFORTIC S 360 is a pharmaceutical formulation containing Mycophenolic Acid Delayed-Release Tablets USP 360 mg. Mycophenolic Acid belongs to a class of medicines known as immunosuppressants. It is used to help prevent organ rejection in patients who have undergone kidney transplantation, as part of a combination immunosuppressive treatment regimen prescribed by a qualified healthcare professional.\n\nOrgan transplantation is an important medical procedure that helps patients with end-stage organ disease improve their quality of life. However, the body's immune system may recognize a transplanted organ as foreign and attempt to attack it. This immune response can lead to organ rejection.\n\nMYCOFORTIC S 360 contains Mycophenolic Acid, an active pharmaceutical ingredient that helps suppress certain immune responses. It works by inhibiting the proliferation of lymphocytes, which are important cells involved in the body's immune response.\n\nWith its delayed-release tablet formulation, MYCOFORTIC S 360 is designed to deliver Mycophenolic Acid through a specialized release mechanism. It is intended for use under strict medical supervision as part of an individualized post-transplant treatment plan.",
"price": 816.0,
"discountamount": 245.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2510,
"imageuri": "https://productimages.withfloats.com/actual/6ae5ddc7bc27d43423ad0aec.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ae5ddc7bc27d43423ad0aec.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-31T12:23:32.198Z",
"updatedon": "2026-10-31T12:23:32.198Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//mycophenolic-acid-delayed-release-tablets-usp-360-mg/2510",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MYCOFORTIC S 360",
"category": null,
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ae5dbe40b7c3d020d7c3b40",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Combipack Of Vonoprazan Tablets 20 mg,Clarithromycin Tablets IP 500 mg & Amoxycillin Capsules IP 500",
"description": "VONOSTRUM HP KIT is a pharmaceutical combination pack containing Vonoprazan Tablets 20 mg, Clarithromycin Tablets IP 500 mg, and Amoxicillin Capsules IP 500 mg. This combination is designed for use as part of a physician-prescribed treatment regimen for Helicobacter pylori (H. pylori) infection, a type of bacterial infection associated with the stomach and gastrointestinal tract.\n\nVONOSTRUM HP KIT combines an acid-suppressing agent with two antibiotics to support H. pylori eradication therapy. The combination works through different mechanisms: Vonoprazan helps reduce stomach acid production, while Clarithromycin and Amoxicillin act against susceptible bacterial infections.\n\nWith its convenient combipack formulation, VONOSTRUM HP KIT brings three complementary medicines together in one treatment pack, helping simplify the prescribed treatment schedule.",
"price": 149.0,
"discountamount": 40.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2509,
"imageuri": "https://productimages.withfloats.com/actual/6ae5dbe783548115dde7d54d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ae5dbe783548115dde7d54d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-31T12:15:32.163Z",
"updatedon": "2026-10-31T12:15:32.163Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//combipack-of-vonoprazan-tablets-20-mg-clarithromycin-tablets-ip-500-mg-amoxycillin-capsules-ip-500/2509",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VONOSTRUM HP KIT",
"category": null,
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ae5d88f695d7aeb49179417",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Triamcinolone Acetonide Injection 40 mg IP",
"description": "TRISULPHON CORT is a pharmaceutical formulation containing Triamcinolone Acetonide Injection 40 mg IP, belonging to the corticosteroid class of medicines. Triamcinolone Acetonide is a synthetic corticosteroid widely recognized for its anti-inflammatory and immunosuppressive properties. It is used under appropriate medical supervision to help manage various inflammatory, allergic, and immune-related conditions, depending on the prescribed route of administration and approved product indications.\n\nCorticosteroids play an important role in modern medical treatment because of their ability to regulate inflammatory responses within the body. By reducing the release and activity of certain substances responsible for inflammation, Triamcinolone Acetonide helps healthcare professionals manage conditions associated with swelling, redness, irritation, and inflammatory discomfort.\n\nTRISULPHON CORT Injection is intended for use under the guidance of qualified healthcare professionals. Its administration, dosage, and treatment duration should always be determined by a registered medical practitioner according to the patient's medical condition and individual requirements.",
"price": 165.0,
"discountamount": 45.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2508,
"imageuri": "https://productimages.withfloats.com/actual/6ae5d892fe30914231ab3937.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ae5d892fe30914231ab3937.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-31T12:01:19.584Z",
"updatedon": "2026-10-31T12:01:19.584Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//triamcinolone-acetonide-injection-40-mg-ip/2508",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TRISULPHON CORT",
"category": null,
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ae5d554245214b8e9f4b2fe",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Combipack of Amoxicillin Tablets USP,Omeprazole Capsules IP & Tinidazole Tablets IP",
"description": "PANTOSTRUM OME HP KIT is a three-in-one combipack of Amoxicillin 750 mg Tablets USP, Omeprazole 20 mg Capsules IP, and Tinidazole 500 mg Tablets IP. Each component acts differently, and a doctor may prescribe them together for certain stomach and gut conditions. The kit is meant to be used only on a qualified physician’s advice.\n\nWhat Is Inside the Kit\nComponent\tDrug class\tPrimary role\nAmoxicillin 750 mg Tablets USP\tPenicillin-type antibiotic\tActs against susceptible bacteria\nOmeprazole 20 mg Capsules IP\tProton Pump Inhibitor (PPI)\tLowers stomach acid\nTinidazole 500 mg Tablets IP\tNitroimidazole antimicrobial\tActs against certain anaerobic bacteria and protozoa\nAmoxicillin 750 mg\n\nAmoxicillin is a broad-spectrum antibiotic from the penicillin family. It blocks bacteria from building their cell walls, so the bacteria cannot survive. Within a multi-drug regimen, it targets susceptible bacteria linked to gastrointestinal infection. Whether to use it is the prescriber’s decision, guided by antibiotic stewardship guidelines.\n\nOmeprazole 20 mg\n\nOmeprazole is a PPI. It switches off the proton pumps in the stomach lining that produce acid, so the stomach becomes less acidic. It is widely used for acid-related conditions such as GERD and peptic ulcer disease. In a combination regimen, lower acid levels can support the overall treatment.\n\nTinidazole 500 mg\n\nTinidazole belongs to the nitroimidazole group. It damages the DNA of susceptible anaerobic bacteria and protozoa, which stops them from multiplying. It is prescribed for specific infections under medical supervision, and in this kit it adds a further antimicrobial effect where clinically suitable.",
"price": 125.0,
"discountamount": 37.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2507,
"imageuri": "https://productimages.withfloats.com/actual/6ae5d5567b5622859fa6fbd0.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ae5d5567b5622859fa6fbd0.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-31T11:47:32.806Z",
"updatedon": "2026-10-31T11:47:32.806Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//combipack-of-amoxicillin-tablets-usp-omeprazole-capsules-ip-tinidazole-tablets-ip/2507",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PANTOSTRUM OME HP KIT",
"category": null,
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ae2fef4545d3197abde920c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Faropenem Disperible Tablets 100 mg",
"description": "Faropinom 100 DT is a prescription-only antibiotic that provides 100 mg of Faropenem in a dispersible tablet. Faropenem is a penem-type beta-lactam, and doctors use it to treat bacterial infections only when the causative organism is likely to respond to it.\n\nAbout Faropinom 100 DT\n\nThe active ingredient, Faropenem, stops bacteria from building a proper cell wall. The weakened bacteria cannot survive, which helps the body clear a susceptible infection.\n\nThe tablet is meant to be mixed into water before it is taken. This can suit patients who find whole tablets hard to swallow. It should be used strictly as prescribed and according to the leaflet in the pack.\n\nProduct Snapshot\nFeature\tDetails\nBrand\tFaropinom 100 DT\nActive ingredient\tFaropenem 100 mg\nClass\tPenem beta-lactam antibiotic\nForm\tDispersible tablet\nMode of action\tBlocks bacterial cell-wall synthesis\nAvailability\tPrescription-only; subject to Indian regulations\nPurpose\tTreating susceptible bacterial infections on a doctor’s advice\nWhere Faropenem May Be Used\n\nWhether Faropenem is chosen depends on the patient’s condition, the bacteria involved (suspected or confirmed), prevailing treatment guidelines and the approved product information. Infections for which it may be considered include:\n\nRespiratory infections: bacterial infections of the airways or lungs, where the organism is sensitive to Faropenem.\nUrinary infections: bacterial infections of the bladder or wider urinary tract, at a clinician’s discretion.\nEar, nose and throat infections: certain bacterial infections of the ears, throat or sinuses, after examination.\nSkin and soft-tissue infections: selected bacterial skin infections, depending on severity and the organisms responsible.\nOther infections: any further use must follow approved indications, laboratory susceptibility and the treating doctor’s judgement.\n\nPlease note: This antibiotic does not suit every infection. It should never be assumed appropriate for all chest, urinary, skin or genital conditions. Only a qualified healthcare professional can decide whether it is right for a particular patient.\n\nNotable Characteristics\n\n1. Bactericidal action. Faropenem attacks susceptible bacteria by interfering with the machinery that builds their cell walls. How well it works depends on the species and its susceptibility.\n\n2. Activity against some enzyme-producing bacteria. Certain bacteria make beta-lactamase enzymes that disable some beta-lactam antibiotics. Faropenem can work against some of these organisms, but results differ by bacterium and resistance mechanism. It is not a universal answer to resistant infections.\n\n3. Easy-to-prepare format. The tablet is dispersed in water following the pack instructions, which helps those who struggle with swallowing conventional tablets.\n\n4. Focused treatment. Matched to the right infection, it targets the responsible bacteria. Choosing the right antibiotic improves outcomes and limits needless antibiotic exposure.\n\n5. Oral route. When oral therapy is clinically suitable, treatment can proceed without injections. The prescriber decides the route based on the patient’s condition.\n\nHow Faropenem Works\n\nFaropenem attaches to penicillin-binding proteins, which bacteria rely on to assemble and maintain their cell walls. With these proteins blocked, the wall cannot form properly, the bacterial structure weakens and the cell dies. This makes Faropenem bactericidal against susceptible organisms. It does not act on viruses and cannot treat every bacterial infection.\n\nDosing and Administration\n\nThe dose is set by the doctor after considering age, body weight (where relevant), the type and seriousness of the infection, and kidney function.\n\nDose: use only the strength and quantity prescribed.\nFrequency: follow the daily schedule given to you; do not alter it yourself.\nDuration: finish the prescribed course without lengthening or shortening it unless your doctor says so.\nPreparation: disperse the tablet as directed in the leaflet or by your pharmacist.\nMissed dose: check the leaflet or ask a pharmacist. Never double up to make up for a forgotten dose.\n\nNo single dosing plan fits all patients, so a general range should never replace a personal prescription.\n\nPossible Side Effects\n\nAs with other antibiotics, reactions can occur, and they vary from person to person.\n\nMilder effects may include:\n\nNausea or stomach upset\nAbdominal discomfort\nLoose stools or diarrhoea\nRash or itching\nHeadache or dizziness\n\nSpeak to a healthcare professional if these continue, become bothersome or get worse.\n\nGet medical help promptly for:\n\nSerious allergy: swelling of the face, lips, tongue or throat, or trouble breathing is an emergency.\nSevere diarrhoea: persistent, watery or bloody stools may signal a serious antibiotic-related complication.\nSevere skin reaction: widespread rash, blisters or peeling skin needs urgent assessment.\nLiver concerns: yellow skin or eyes, or dark urine, should be checked quickly.\n\nThis list is not exhaustive. Refer to the product information and your doctor for advice specific to you.\n\nPrecautions and Warnings\nAllergies: tell your doctor about any past allergy to Faropenem, penicillins, cephalosporins or other beta-lactams.\nKidney health: report any kidney disease or reduced function, as it can affect suitability and dosing.\nPregnancy and breastfeeding: consult your doctor first if you are pregnant, planning pregnancy or nursing. Use only after a personal benefit–risk assessment.\nOther medicines: share a full list of prescription drugs, over-the-counter products and supplements so interactions can be checked.\nAntibiotic resistance: take Faropenem only for a suitable bacterial infection. Misuse and incorrect dosing fuel resistance.\nMedical history: discuss existing conditions and earlier drug reactions before starting.\nWho Is It For?\n\nFaropinom 100 DT may be considered for patients who need an antibiotic for a susceptible bacterial infection and for whom this dispersible form is suitable. The prescriber decides based on examination, the likely or confirmed organism, individual risk factors and current guidance. It should not be self-started for fever, cough or sore throat without first establishing that an antibiotic is needed.\n\nBuying Faropinom 100 DT in India\n\nBefore purchasing, confirm the brand, strength, manufacturer and the legitimacy of the seller. For safety:\n\nGet a prescription from a registered medical practitioner.\nBuy from a licensed pharmacy or a duly authorised online pharmacy.\nInspect the name, strength, batch number, expiry date and pack condition.\nStore it as the packaging directs.\nAsk the pharmacist if anything is unclear.\n\nPrice and availability: these differ by manufacturer, pack size, pharmacy and location. Confirm current details with a licensed seller rather than an unverified figure.\n\nFrequently Asked Questions\n\n1. What is Faropinom 100 DT prescribed for?\nIt contains Faropenem 100 mg and is used for certain bacterial infections when the organism is susceptible and the medicine is clinically suitable.\n\n2. Is it an antibiotic?\nYes. Faropenem is a penem-class beta-lactam that disrupts bacterial cell-wall formation.\n\n3. What is the active ingredient?\nFaropenem 100 mg. Check the pack for full composition details.\n\n4. Will it cure a common cold?\nNo. Colds are viral, and antibiotics do not act on viruses.\n\n5. How do I take it?\nExactly as prescribed. Prepare the dispersible tablet in water as described in the leaflet or by your pharmacist.\n\n6. What is the right dose?\nIt depends on the infection, your age, kidney function and other individual factors. Follow your doctor’s prescription.\n\n7. How long is the course?\nThe duration depends on the infection and your response. Complete the course unless your doctor changes it.\n\n8. What side effects can occur?\nStomach upset, nausea, diarrhoea, headache and skin reactions are possible. Seek advice if they persist or become severe.\n\n9. Can it cause diarrhoea?\nYes, as antibiotics can. Contact a healthcare professional quickly if it is severe, long-lasting or bloody.\n\n10. Can I stop once I feel better?\nDo not stop or alter treatment on your own. Talk to your doctor about side effects or if you think treatment is no longer needed.\n\n11. Is it safe in pregnancy?\nA doctor must assess this individually. Do not use it in pregnancy without medical advice.\n\n12. Can I use it while breastfeeding?\nAsk your doctor first. The decision rests on available safety data and your circumstances.\n\n13. Can people with kidney problems take it?\nThey should tell their doctor beforehand, who will decide on suitability and any adjustment.\n\n14. Is Faropenem a penicillin?\nNo, it is a penem. Both are beta-lactams, so discuss any antibiotic allergy history with your prescriber.\n\n15. Is alcohol allowed during treatment?\nAsk your doctor or pharmacist, especially if you have other conditions or take other medicines. Avoid alcohol if it worsens symptoms.\n\n16. What if I miss a dose?\nConsult the leaflet or your pharmacist. Do not take a double dose unless a professional tells you to.\n\n17. Does it work on resistant bacteria?\nIt may act on certain bacteria that resist some other antibiotics, but this depends on the organism and resistance mechanism. Medical assessment is essential.\n\n18. Can it be used for any infection?\nNo. It is for suitable bacterial infections only, chosen through clinical assessment and, where needed, lab testing.\n\n19. What does it cost in India?\nConfirm the current price with a licensed pharmacy, as it varies by pack size, maker and location.\n\n20. Where can I buy it?\nEnquire at a licensed local or authorised online pharmacy. A valid prescription may be required under applicable rules.\n\nConclusion\n\nFaropinom 100 DT is a dispersible Faropenem 100 mg antibiotic for selected bacterial infections, to be used under a qualified healthcare professional’s guidance. It works by disrupting bacterial cell-wall formation, and the dispersible form offers an alternative for patients who find standard tablets difficult.\n\nResponsible use depends on accurate diagnosis, the right antibiotic choice, sticking to the prescribed regimen and watching for side effects. Always consult a healthcare professional before starting, stopping or changing antibiotic treatment.",
"price": 590.0,
"discountamount": 177.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2506,
"imageuri": "https://productimages.withfloats.com/actual/6ae2fef754689b1ff0217bf5.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ae2fef754689b1ff0217bf5.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-29T08:08:20.798Z",
"updatedon": "2026-10-29T08:08:20.798Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//faropenem-disperible-tablets-100-mg/2506",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Faropinom 100 DT",
"category": null,
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad73c502f1fbe0284e2dcb5",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Ketorolac Tromethamine Ophthalmic Solution",
"description": "CIPVISION KEYPROFEN 0.5 is an ophthalmic formulation containing Ketorolac Tromethamine 0.5% w/v, a non-steroidal anti-inflammatory drug (NSAID) used in specific eye-care situations. It works by reducing the production of prostaglandins, chemical substances that contribute to pain and inflammation. This action may help manage certain inflammatory eye symptoms when the medicine is prescribed for an appropriate condition.\n\nCIPVISION KEYPROFEN 0.5 is intended for topical application to the eyes under the supervision of a qualified healthcare professional. Its suitability depends on the patient's symptoms, clinical diagnosis, and the approved product information.\n\nFor pharmacies, medical distributors, healthcare professionals, and pharmaceutical product catalogues, CIPVISION KEYPROFEN 0.5 represents an ophthalmic product containing a recognised anti-inflammatory ingredient. Appropriate product information helps users understand its intended role, administration requirements, and important precautions.\nComposition of CIPVISION KEYPROFEN 0.5\nThe stated active ingredient in CIPVISION KEYPROFEN 0.5 is:\n\nKetorolac Tromethamine 0.5% w/v: This medicine belongs to the NSAID class. It inhibits cyclooxygenase enzymes involved in the production of prostaglandins, helping reduce inflammatory activity and associated discomfort in suitable ophthalmic conditions.\n\nThe complete formulation, inactive ingredients, pack size, and approved therapeutic indications should be verified using the product packaging and official prescribing information.\nKey Features of CIPVISION KEYPROFEN 0.5 Eye Drops\nCIPVISION KEYPROFEN 0.5 has several important characteristics relevant to ophthalmic care:\n- NSAID-based formulation: Contains Ketorolac Tromethamine, a non-steroidal anti-inflammatory medicine.\n- Inflammation control: Helps manage inflammation in specific eye conditions when prescribed appropriately.\n- Prostaglandin reduction: Acts by inhibiting enzymes involved in the formation of inflammatory mediators.\n- Topical eye application: Designed for administration directly into the eye according to prescribed directions.\n- Clinically guided use: Requires an appropriate diagnosis and advice from an eye-care professional.\nThe potential role of this medicine depends on the underlying eye condition, the approved product indications, and the patient's individual health requirements.\nWhat Is CIPVISION KEYPROFEN 0.5 Used For?\nCIPVISION KEYPROFEN 0.5 may be prescribed for selected eye conditions in which reducing inflammation, itching, or pain is clinically appropriate. The precise indication should be confirmed from the approved product information.\n1. Management of Selected Inflammatory Eye Conditions\nInflammation of the eye may cause redness, irritation, watering, and discomfort. Ketorolac Tromethamine reduces the production of prostaglandins involved in the inflammatory response. An ophthalmologist can determine whether this medicine is suitable after assessing the cause of the symptoms.\n2. Relief of Certain Types of Eye Discomfort\nKetorolac Tromethamine ophthalmic preparations may help relieve ocular pain in approved clinical situations. Some formulations are also indicated for itching associated with seasonal allergic conjunctivitis. These uses depend on the specific product's approved labelling.\n\nPersistent eye pain, redness, or irritation should not be treated through self-medication because these symptoms can arise from infections, injuries, or other conditions requiring different treatment.\n3. Eye Care Following Certain Surgical Procedures\nSome Ketorolac Tromethamine ophthalmic products are used to manage pain and inflammation associated with eye surgery, including cataract procedures. Postoperative treatment must follow the ophthalmologist's instructions because the appropriate medicine, dosage, and duration depend on the procedure and the patient's recovery.\n\nAlways verify whether CIPVISION KEYPROFEN 0.5 is approved for the intended postoperative use before including a specific surgical indication in product information.\nHow Does CIPVISION KEYPROFEN 0.5 Work?\nKetorolac Tromethamine belongs to the non-steroidal anti-inflammatory drug category. Its action involves inhibiting cyclooxygenase (COX) enzymes, which help produce prostaglandins.\n\nProstaglandins participate in inflammatory processes and pain signalling. By reducing their production, Ketorolac Tromethamine can help control inflammation and associated discomfort in certain eye conditions.\n\nUnlike corticosteroids, Ketorolac Tromethamine is a non-steroidal anti-inflammatory medicine. However, it is not appropriate for every eye complaint. It does not treat all causes of eye redness or pain, and suspected infections may require a different treatment approach.\nPotential Benefits of CIPVISION KEYPROFEN 0.5\nWhen prescribed for an appropriate indication, CIPVISION KEYPROFEN 0.5 may offer the following benefits:\n- Anti-inflammatory action: Helps reduce inflammatory activity in selected ophthalmic conditions.\n- Management of eye pain: May relieve pain in specific clinical situations covered by the relevant product indication.\n- Non-steroidal treatment option: Provides an alternative mechanism to corticosteroid-based medicines for appropriate cases.\n- Local administration: Allows the active ingredient to be delivered directly to the eye.\n- Support for ophthalmic treatment: May be included in a treatment plan developed by an eye-care professional.\nThe response to treatment varies according to the diagnosis, severity of the condition, individual health factors, and adherence to the prescribed instructions. The product should not be considered a universal treatment for eye pain or inflammation.\nHow to Use CIPVISION KEYPROFEN 0.5 Eye Drops\nUse CIPVISION KEYPROFEN 0.5 only according to your ophthalmologist's instructions and the product leaflet.\n1. Clean your hands: Wash and dry your hands before handling the eye-drop bottle.\n2. Check the bottle: Confirm the product name, expiry date, and administration instructions before use.\n3. Prevent contamination: Keep the dropper tip away from your eyes, eyelids, fingers, and other surfaces.\n4. Follow the prescribed dosage: Use only the recommended number of drops and the prescribed frequency.\n5. Use other eye medicines carefully: Ask your healthcare professional how much time to leave between different ophthalmic preparations.\n6. Avoid prolonged use: Do not continue treatment longer than recommended, as extended NSAID use may increase the risk of eye complications.\n7. Follow storage instructions: Store the medicine as directed on its packaging and observe any instructions concerning use after opening.\n8. Do not share the bottle: Sharing eye drops can increase the risk of contamination.\n9. Attend follow-up appointments: Follow your ophthalmologist's advice, particularly when using the medicine after eye surgery.\nIf you miss a dose, follow the instructions in the product leaflet or consult your healthcare professional. Do not double the next dose to compensate for a missed application.\nPrecautions and Safety Information\nAlthough Ketorolac Tromethamine eye drops can be useful in appropriate clinical settings, they may cause side effects and require additional caution in certain patients.\nPossible Side Effects\nSome people may experience temporary burning, stinging, irritation, or discomfort after applying the drops. Ophthalmic NSAIDs can also delay healing and, in susceptible individuals, increase the risk of corneal complications. Rare cases of serious corneal damage have been reported.\n\nContact your ophthalmologist if symptoms persist or worsen. Seek urgent medical assessment if you experience severe eye pain, significant changes in vision, marked redness, or other serious symptoms.\nImportant Precautions\n- Corneal conditions: Tell your doctor if you have corneal disease, a damaged eye surface, or delayed healing.\n- Dry eyes: Inform your healthcare professional if you have severe dry eye symptoms or another condition affecting the eye surface.\n- Allergies: Disclose any previous allergic reaction to Ketorolac, aspirin, or other NSAIDs.\n- Bleeding risks: Discuss any bleeding disorder or medicine that may increase bleeding risk.\n- Eye surgery: Follow your surgeon's instructions, as postoperative use requires appropriate monitoring.\n- Pregnancy and breastfeeding: Consult your doctor before using the medicine during pregnancy or while breastfeeding.\n- Other medicines: Inform your healthcare professional about all medicines and eye preparations you currently use.\nCIPVISION KEYPROFEN 0.5 is intended for ophthalmic use only. Keep it out of children's reach and never use it beyond the labelled expiry date.\nWhy Consider CIPVISION KEYPROFEN 0.5 for Pharmaceutical Product Portfolios?\nCIPVISION KEYPROFEN 0.5 combines a distinct pharmaceutical brand identity with Ketorolac Tromethamine 0.5% ophthalmic solution. The formulation may be relevant to product catalogues serving pharmacies, medical distributors, and healthcare professionals involved in ophthalmic care.\n\nClear product information supports responsible pharmaceutical communication by explaining the active ingredient, its mechanism of action, appropriate clinical applications, and safety considerations.\n\nFor accurate product representation, always verify the approved strength, indications, contraindications, dosage, storage requirements, and instructions against the official packaging and prescribing information.\nConclusion\nCIPVISION KEYPROFEN 0.5 Eye Drops contains Ketorolac Tromethamine 0.5% w/v, a non-steroidal anti-inflammatory ingredient used in selected ophthalmic conditions. By inhibiting prostaglandin production, it helps manage inflammation and may relieve pain in specific approved clinical settings.\n\nCorrect administration, appropriate patient selection, and awareness of potential side effects are essential for responsible use. Consult a qualified eye-care professional for treatment guidance and refer to the approved product information for complete details.\nFrequently Asked Questions (FAQs)\n1. What is CIPVISION KEYPROFEN 0.5?\nCIPVISION KEYPROFEN 0.5 is an ophthalmic solution containing Ketorolac Tromethamine 0.5% w/v, according to the composition provided. It is intended for specific eye-care applications under professional guidance.\n2. What is CIPVISION KEYPROFEN 0.5 used for?\nKetorolac Tromethamine ophthalmic preparations may be prescribed for certain inflammatory eye conditions, itching associated with seasonal allergic conjunctivitis, or pain and inflammation following specific eye procedures. The approved uses of CIPVISION KEYPROFEN 0.5 must be confirmed from its official product information.\n3. How does Ketorolac Tromethamine work in the eyes?\nKetorolac Tromethamine inhibits cyclooxygenase enzymes involved in prostaglandin production. This helps reduce inflammatory activity and associated pain in appropriate ophthalmic conditions.\n4. Can CIPVISION KEYPROFEN 0.5 be used without a prescription?\nUse this medicine only under appropriate medical guidance. An eye-care professional should determine whether it is suitable, particularly because NSAID eye drops can affect healing and may cause complications in susceptible patients.\n5. What precautions should be taken while using CIPVISION KEYPROFEN 0.5?\nAvoid contaminating the dropper tip, follow the prescribed dosage, and do not use the drops for longer than recommended. Inform your doctor about corneal problems, allergies to NSAIDs, bleeding disorders, and other medicines you use.\n6. How should CIPVISION KEYPROFEN 0.5 be stored?\nFollow the storage instructions on the product packaging. Keep the container closed as directed, protect it from unsuitable storage conditions, and observe any instructions concerning disposal after opening.\n\n\n",
"price": 80.0,
"discountamount": 56.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2503,
"imageuri": "https://productimages.withfloats.com/actual/6ad73c52dc6a6c6c9945f376.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad73c52dc6a6c6c9945f376.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:02:56.893Z",
"updatedon": "2026-10-20T10:02:56.893Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//ketorolac-tromethamine-ophthalmic-solution/2503",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION KEYPROFEN 0.5",
"category": "Opthalmology Range",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}